1993.8至今:北大医院感染科,历任住院医、主治医、副主任医师、副教授、主任医师、教授;
2009.2-2010.8:美国哈佛医学院/美国麻省总院,博士后;
1987.9-1993.7:中山医科大学临床医学系。
题:主持和参与多项国家自然科学基金科技重大专项。
论文:
①Wang G, Tanaka A, Zhao Hong, , Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int. 2021, 15(2):223-257. (共一)
②Zhang Chi, Li Jiawen, Wu Zhao, Zhao Hong, Gui-Qiang Wang. Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis. J Clin Transl Hepatol. 2021, 9(5):615-625.
③Zhao Hong, Zhang Chi, Zhu Qi, , Guiqiang Wang. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. Int Immunopharmacol. 2021, 97:107702.
Zhao Hong, Zhang Chi, Chen Xian-Xiang, Zhu Qi, Huang Wen-Xiang, Zeng Yi-Lan, Liu Ying-Xia, Li Guo-Jun, Du Wei-Jun, Yao Jing, Li Jia-Wen, Peng Peng, Wang Gui-Qiang. The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive. Infect Dis Poverty. 2021, 10(1):45.